ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173516 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173516; 2) Community: the network communities that were significantly associated with the response to NSC 173516; 3) Molecule: the relationships between components within communities and NSC 173516; 4) MDR: the compounds that were significantly associated with the NSC 173516.

NSC Compound Enrichment Correlation
NSC 762611 Null 0.0209467683758286 0.15498142
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.0209467683758286 0.3826437
NSC 93674 Oxyacanthan-7,12'-diol, 6,6'-dimethoxy-2,2'-dimethyl- 0.0209467683758286 0.42296365
NSC 330500 Macbecin II 0.0222343516878695 0.32234852
NSC 626715 10-EdAM 0.0222343516878695 0.57328125
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0222343516878695 0.26915627
NSC 652151 Null 0.0222343516878695 0.4018598
NSC 652565 Null 0.0222343516878695 0.2798268
NSC 685833 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- 0.0222343516878695 0.28587946
NSC 710547 2H,6H-Pyrazolo[3,4,5-mn]pyrimido[5,6,1-de]acridine- 5,7-dione, 11-methoxy-2,6-bis[2-(dimethylamino)ethyl]- 0.0222343516878695 0.41841971
Total:87  Current:45    [First] [Prev] [Next] [Last]